These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19100422)

  • 21. Alendronate in kidney transplant patients: a single-center experience.
    Toro J; Gentil MA; García R; Pérez-Valdivia MA; García Avellano E; Algarra GR; Pereira P; González-Roncero F; Mateos J
    Transplant Proc; 2005 Apr; 37(3):1471-2. PubMed ID: 15866643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
    Dejardin A; Devogelaer JP; Goffin E
    N Engl J Med; 2004 May; 350(22):2306-8; author reply 2306-8. PubMed ID: 15168423
    [No Abstract]   [Full Text] [Related]  

  • 24. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
    Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
    Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D status, bone mineral density, and inflammation in kidney transplantation patients.
    Sezer S; Yavuz D; Canoz MB; Ozdemir FN; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2823-5. PubMed ID: 19765446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
    Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients.
    Malyszko J; Malyszko JS; Pawlak K; Konstantynowicz J; Wolczynski S; Kaczmarski M; Mysliwiec M
    Transplant Proc; 2005 Jun; 37(5):2151-3. PubMed ID: 15964364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation.
    Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D
    Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L; Casez JP; Bekri S; Gigante M; Champenois I; Cassuto-Viguier E; Jaeger P
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
    Altundal H; Sayrak H; Yurtsever E; Göker K
    J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alendronate for treatment of renal transplant patients with osteoporosis.
    Chong C
    Transplant Proc; 2005 Dec; 37(10):4639; author reply 4639. PubMed ID: 16387188
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of alendronate on early bone loss of renal transplant recipients.
    Abediazar S; Nakhjavani MR
    Transplant Proc; 2011 Mar; 43(2):565-7. PubMed ID: 21440762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density in kidney transplant recipients and patients on hemodialysis: a comparison with healthy individuals.
    Nouri-Majalan N; Sanadgol H; Rahimian M; Soleimani H
    Iran J Kidney Dis; 2008 Jul; 2(3):154-9. PubMed ID: 19377230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G
    Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of alendronate vs alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study.
    Braith RW; Conner JA; Fulton MN; Lisor CF; Casey DP; Howe KS; Baz MA
    J Heart Lung Transplant; 2007 Feb; 26(2):132-7. PubMed ID: 17258146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate.
    Wang CJ; Wang FS; Yang KD; Huang CC; Lee MS; Chan YS; Wang JW; Ko JY
    Arch Orthop Trauma Surg; 2008 Sep; 128(9):901-8. PubMed ID: 18060419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alendronate for treatment of renal transplant patients with osteoporosis.
    Torregrosa JV; Moreno A; Gutierrez A; Vidal S; Oppenheimer F
    Transplant Proc; 2003 Jun; 35(4):1393-5. PubMed ID: 12826169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.